Table 1.
No MI/Arrest (n=804 548) | MI/Arrest (n=5332) | Unadjusted Odds Ratio (95% CI) for MI/Arrest | No Stroke (n=807 875) | Stroke (n=2005) | Unadjusted Odds Ratio (95% CI) For Stroke | |
---|---|---|---|---|---|---|
Age, y (mean±SD) | 55.4 (±17.1) | 69.8 (±13.0) | 1.059 (1.057–1.061) | 55.4 (±17.2) | 70.0 (±13.6) | 1.06 (1.056–1.063) |
Sex (men) (%) | 42.52 | 57.58 | 1.83 (1.74–1.94) | 42.6 | 48.8 | 1.29 (1.18–1.4) |
ASA class* 1 (%) (Ref=1) | 9.90 | 0.24 | 9.86 | 0.40 | ||
2 | 46.00 | 7.71 | 6.82 (3.93–11.85) | 45.83 | 10.9 | 5.89 (2.91–11.93) |
3 | 37.62 | 48.9 | 52.83 (30.63–91.11) | 37.65 | 56.26. | 36.94 (18.43–74.04) |
4 | 6.20 | 38.14 | 248.78 (144.19–429.24) | 6.35 | 30.22 | 117.58 (58.53–236.21) |
5 | 0.27 | 5.09 | 767.5 (439.25–1341.04) | 0.30 | 2.19 | 182.6 (85.87–388.26) |
Diabetes mellitus (%) | 14.79 | 32.15 | 2.73 (2.58–2.89) | 14.9 | 26.78 | 2.09 (1.9–2.31) |
Alcohol use >2 drinks/day in 2 wks before admission (%) | 2.61 | 3.98 | 1.54 (1.34–1.77) | 2.6 | 4.84 | 1.89 (1.54–2.32) |
Chemotherapy (%) | 1.06 | 1.82 | 1.73 (1.42–2.12) | 1.06 | 1.35 | 1.27 (0.87–1.86) |
Disseminated cancer (%) | 1.93 | 4.24 | 2.25 (1.97–2.57) | 1.94 | 2.74 | 1.42 (1.09–1.86) |
Paraplegia (%) | 0.49 | 0.99 | 2.04 (1.56–2.68) | 0.49 | 0.75 | 1.53 (0.92–2.54) |
Quadriplegia (%) | 0.13 | 0.43 | 3.38 (2.24–5.12) | 0.13 | 0.15 | 1.15 (0.37–3.58) |
Hemiplegia (%) | 0.92 | 2.87 | 3.17 (2.70–3.73) | 0.92 | 6.93 | 8.01 (6.74–9.54) |
Smoker within 1 y (%) | 20.68 | 24.46 | 1.24 (1.17–1.32) | 20.69 | 26.43 | 1.38 (1.25–1.52) |
Pack‐year of smoking | 10.59 | 23.73 | 1.02 (1.01–1.02) | 10.64 | 23.44 | 1.01 (1.01–1.02) |
Esophageal varices (%) | 0.12 | 0.32 | 2.72 (1.68–4.4) | 0.12 | 0.05 | 0.42 (0.06–2.98) |
Chronic obstructive pulmonary disease (%) | 4.73 | 16.97 | 4.12 (3.83–4.42) | 4.79 | 14.11 | 3.27 (2.88–3.71) |
Ascites (%) | 1.01 | 5.29 | 5.46 (4.83–6.17) | 1.04 | 2.19 | 2.14 (1.59–2.89) |
Congestive heart failure (%) | 0.83 | 7.28 | 9.41 (8.46–10.46) | 0.86 | 4.49 | 5.41 (4.38–6.7) |
Myocardial infarction (%) | 0.58 | 5.61 | 10.2 (9.04–11.5) | 0.60 | 3.84 | 6.57 (5.22–8.26) |
Previous cardiac surgery (%) | 5.73 | 21.23 | 4.43 (4.15–4.74) | 5.80 | 18.45 | 3.67 (3.28–4.11) |
Previous percutaneous coronary intervention (%) | 5.33 | 17.74 | 3.83 (3.57–4.11) | 5.40 | 12.77 | 2.56 (2.25–2.93) |
Angina (%) | 0.68 | 4.05 | 6.12 (5.33–7.04) | 0.70 | 2.84 | 4.14 (3.18–5.4) |
Peripheral vascular disease (%) | 4.00 | 17.18 | 4.98 (4.63–5.35) | 4.06 | 13.17 | 3.58 (3.14–4.08) |
Hypertension on medication (%) | 45.65 | 77.83 | 4.18 (3.92–4.46) | 45.8 | 77.61 | 4. 1 (3.69–4.56) |
Acute renal failure (%) | 0.55 | 5.98 | 11.47 (10.2–12.89) | 0.58 | 3.14 | 5.55 (4.31–7.14) |
Dialysis (%) | 1.97 | 12.23 | 6.93 (6.38–7.54) | 2.03 | 5.79 | 2.97 (2.46–3.58) |
Steroid (%) | 3.05 | 7.48 | 2.57 (2.32–2.85) | 3.08 | 5.99 | 2.01 (1.67–2.41) |
Stroke with neurologic deficit (%) | 2.30 | 7.95 | 3.67 (3.32–4.05) | 2.31 | 15.91 | 8.02 (7.11–9.04) |
Stroke with no neurologic deficit (%) | 2.01 | 6.06 | 3.14 (2.81–3.52) | 2.02 | 9.93 | 5.35 (4.62–6.2) |
Transient ischemic attack (%) | 2.89 | 7.69 | 2.8 (2.53–3.09) | 2.89 | 15.31 | 6.07 (5.37–6.86) |
Weight loss (%) | 2.23 | 6.98 | 3.29 (2.96–3.66) | 2.26 | 4.19 | 1.89 (1.52–2.36) |
Bleeding disorder (%) | 5.52 | 20.46 | 4.4 (4.11–4.71) | 5.58 | 20.75 | 4.43 (3.97–4.93) |
Emergency (%) | 12.39 | 34.02 | 3.65 (3.44–3.86) | 12.50 | 26.63 | 2.54 (2.3–2.81) |
Rest Pain (%) | 2.28 | 11.07 | 5.33 (4.89–5.82) | 2.32 | 8.13 | 3.72 (3.17–4.37) |
White blood count, (109/L) | 8.44 | 10.69 | 8.45 | 9.72 | ||
Hematocrit (%) | 38.98 | 35.02 | 38.95 | 36.61 | ||
Platelet (109/L) | 261.5 | 240.72 | 261.4 | 246.67 | ||
Partial thromboplastin time | 30.79 | 34.61 | 30.82 | 33.91 | ||
International normalized ratio | 1.11 | 1.28 | 1.11 | 1.19 |
ASA class indicates American Society of Anesthesiologists Physical Status Classification; and MI, myocardial infarction.